Renee Louis is a seasoned professional in drug development solutions, specializing in toxicology, DMPK, bioanalytical services, and biomarkers. They hold a B.Sc. in Molecular and Cellular Biology from the University of Arizona and have accumulated extensive experience in business development roles across various organizations, including Spaulding Clinical Research and Covance. As of 2025, they serve as the Director of Business Development at QPS Holdings, LLC, where they enhance sponsor outcomes with comprehensive preclinical and clinical support services. Recognized for their contributions, Renee received the 2013 Gem Club Award and the Largest Territory Growth Award in the same year.